Sponsored by IMI
01 Sep 2017   |   News

Registration is open for the IMI Stakeholder Forum

Patients are at the heart of this year’s event, with a dedicated forum featuring discussions on patient engagement in research and big data and ethics. Brussels, 18-19 October.

IMI encourages all stakeholders in health and medicines R&D to join the Stakeholder Forum: policy makers, academics and researchers, pharmaceutical industry and other sectors with an interest in health research, SMEs and mid-sized enterprises, patient representatives and regulators, representatives of other public-private partnerships and research-funding organisations.

On the first day of the Stakeholder Forum we will be looking at IMI through the lens of open innovation, and discuss the results it is delivering through a dynamic, multi-stakeholder, collaborative innovation ecosystem. Confirmed speakers include:

  • Iain Gillespie | Pro-Vice-Chancellor Research and Enterprise at the University of Leicester
  • Nathalie Moll | Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA)
  • Aled Edwards | Director and CEO of the Structural Genomics Consortium (SGC), Professor at the University of Toronto and Visiting Professor at the University of Oxford | IMI ULTRA-DD project
  • Chantal Mathieu | Professor of Medicine and Program Director of Biomedical Sciences at the Katholieke Universiteit Leuven | IMI INNODIA project
  • Emilio Merlo Pich | Head, Quantitative Medicine & Partnering, CNS Therapeutic Area, Vice-President, Takeda

On the second day, two parallel tracks will focus on examples of IMI’s open innovation in practice: 

1. Patient forum | Confirmed speakers include:

  • Nicola Bedlington | Secretary General, European Patient Forum
  • Jacqueline Broerse | Research Director of the Faculty of Sciences; Full professor of innovation and communication; Director of the Athena Institute (FALW), Vrije Universisiteit Amsterdam
  • James Cusack | Director of Research, Autistica
  • European Medicines Agency (EMA)
  • Lee Wen Hwa  | Director, Oxford Martin Programme on Affordable Medicines at the University of Oxford; Director, Disease Foundations Network, Strategic Alliances at the Structural Genomics Consortium; IMI ULTRA-DD project
  • Julian Isla | Founder and Chairman of the Dravet Syndrome Foundation | President of the Dravet Syndrome European Federation
  • Anders Olauson | Honorary President, European Patient Forum
  • Ilaria Passarani | Head of Food and Health, BEUC
  • Sue Pavitt | Professor of Translational & Applied Health Research at the University of Leeds
  • Eileen Penman | Member of the EPAD Research Participant Panel
  • Tamsin Rose | Director, Progress Works

2. Microbiome forum |​ Confirmed speakers include:

  • Frank Møller Aarestrup | Global Microbial Indentifier
  • Dusko Ehlrich | International Human Microbiome Consortium
  • Wulf Fischer-Knuppertz | CEO & Chairman, Biocrates Life Sciences
  • Artem Khlebnikov | Director Strategic Partnerships, Danone Research
  • Nino Mihokovic |  Quality of Medicines Specialist, European Medicines Agency
  • Alain Pluquet | Corporate VP, Chief Data Officer, bioMerieux
  • Stefan J. Scherer | VP Global Head Correlative Science, Novartis Pharmaceuticals Corporation
  • Kristof Van Emelen | CSO – Product Development, ProDigest
  • Vijay Yajnik | Medical Director, Clinical Science, GI TAU, Takeda


For more information, please visit the event webpage on the IMI website.